Women's Health

Daré Bioscience begins Phase I trial of primary dysmenorrhea therapy

Daré Bioscience has commenced a Phase I clinical trial of its development programme to treat primary dysmenorrhea by delivering diclofenac,…

Inclusive drugs: designing clinical trials for the pregnant population

The inclusion of female participants in clinical trials has been a never-ending battle for almost three decades. The historical tragedy…

US FDA grants approval for Gradalis’ Phase III ovarian cancer trial

The US Food and Drug Administration (FDA) has granted clearance to Gradalis for the Phase III VITAL-V clinical trial of…

Anixa begins Phase Ib trial of breast cancer vaccine

Anixa Biosciences has begun a Phase Ib clinical trial of its preventative breast cancer vaccine.  Being carried out at the Cleveland Clinic in…

Remember the perils of breast cancer in the Awareness Month this year

Despite the advances in the diagnosis and treatment of breast cancer, this condition is still the leading cause of cancer…

Genelux begins Phase III ovarian cancer combination treatment trial

Genelux has commenced the Phase III clinical trial of its Olvimulogene Nanivacirepvec (Olvi-Vec), along with platinum-doublet plus bevacizumab, in platinum-resistant/refractory ovarian cancer…

GSK’s Zejula offers lasting PFS benefit in Phase III ovarian cancer trial

GSK has reported long-term findings from the Phase III PRIMA (ENGOT-OV26/GOG-3012) clinical trial where Zejula (niraparib) offered a lasting and clinically meaningful progression-free…

Dizal reports positive Phase I data for breast cancer therapy

Dizal has reported positive safety and pharmacokinetic findings from the Phase I clinical trial of DZD1516 in HER2 positive metastatic…

Pipeline Moves: Novartis completes Phase II Sjögren’s syndrome trial, advancement prospects jump

This week on Pipeline Moves, we look into the Novartis completion of a Phase II trial in Sjögren's syndrome. We…

Astellas reports Phase III data of fezolinetant for menopause-linked VMS

Astellas Pharma has reported topline findings from the Phase III MOONLIGHT 3 clinical trial of fezolinetant to treat moderate to…